반응 #534965
ord-f0fea5d0162b43f29ed0b2a98925957d
반응 방정식
반응물
시약
반응 조건
후처리
- 1workup.STIRRINGthe mixture was stirred at room temperature for one overnight
- 2기타Reaction mixture
- 3기타was quenched with NaHCO3 (saturated solution)
- 4workup.ADDITIONdiluted with dichloromethane
- 5기타the two phases were separated
- 6기타the organic solvent was evaporated
- 7기타to afford the crude product
- 8기타The crude obtained
- 9workup.STIRRINGthe mixture was stirred at room temperature for 10 minutes
- 10workup.STIRRINGthe mixture was stirred at room temperature for 3 extra hours
- 11기타Reaction mixture
- 12기타was quenched with NaHCO3 (saturated solution)
- 13workup.ADDITIONdiluted with dichloromethane
- 14기타the two phases were separated
- 15기타the organic solvent was evaporated
- 16기타to afford the crude product that
- 17기타was purified by chromatography (methanol-NH3-dichloromethane)
실험 절차
4-Fluoro-6-methyl-1-(4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one hydrochloride (D5) (0.072 mmol, 21 mg) was dissolved in dichloromethane (2 ml) and triethylamine (3 eq., 0.216 mmol, 30 microliters), tetrahydro-4H-pyran-4-one (7 eq., 0.5 mmol, 47 microliters) were added and the mixture was stirred at room temperature for 10 minutes; sodium triacetoxyborohydride (7 eq., 0.5 mmol, 106 mg) was added at room temperature and the mixture was stirred at room temperature for one overnight. Reaction mixture was quenched with NaHCO3 (saturated solution) and diluted with dichloromethane; the two phases were separated and the organic solvent was evaporated to afford the crude product. The crude obtained was dissolved in 1,2-dichloroethane (3 ml) and triethylamine (3 eq., 0.216 mmol, 30 microliters), tetrahydro-4H-pyran-4-one (7 eq., 0.5 mmol, 47 microliters) were added again and the mixture was stirred at room temperature for 10 minutes; sodium triacetoxyborohydride (7 eq., 0.5 mmol, 106 mg) was subsequently added at room temperature and the mixture was stirred at room temperature for 3 extra hours. Reaction mixture was quenched with NaHCO3 (saturated solution) and diluted with dichloromethane; the two phases were separated and the organic solvent was evaporated to afford the crude product that was purified by chromatography (methanol-NH3-dichloromethane) to afford 4-fluoro-6-methyl-1-[1-(tetrahydro-2H-pyran-4-yl)-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one, 10 mg, 42%, M++H=334, which was converted to the HCl salt using 1M HCl in diethyl ether.